Carlsmed Inc. (CARL:NASDAQ) closed at $14.53 on October 23, 2026, down 0.55% on the day. The stock trades 15.7% below its 52-week high of $17.23 and 70.9% above its 52-week low of $8.50. Over the past year, it gained 7.8%. Carlsmed Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, CARL closed higher on 122 days (48%). Its best day was February 26, 2026 (+15.92%) and its worst was December 4, 2025 (-15.19%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 1 time.
Carlsmed is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. We are focused on becoming the standard of care for spine fusion surgery. The aprevo Technology Platform consists of artificial intelligence-enabled software solutions, and interbody implants that we custom design for each patient's unique pathology and vertebral bone topography, and single-use surgical instruments (the "aprevo Technology Platform"). The aprevo Technology Platform was designed to address the limitations of traditional spine fusion surgery and aims to optimize patient outcomes and reduce the need for revision surgeries.
Find more stocks like CARL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.